AstraZeneca has acknowledged in court that its COVID-19 vaccine, Covishield, may cause the rare but serious condition Thrombosis with Thrombocytopenia Syndrome (TTS).

The admission came in response to a lawsuit alleging that the vaccine led to deaths and injuries.

Several countries had previously halted the use of the AstraZeneca vaccine due to blood clot reports.

The World Health Organization recognizes the risks of TTS but maintains that the vaccine's benefits outweigh its risks.

Dr. MV Padma Srivastava has highlighted the serious potential consequences of TTS, such as strokes and heart attacks.

The recent acknowledgement by the vaccine maker has sparked renewed debate and concern over vaccine safety.